propiedad intelectual
Simposio sobre la cadena de suministro de vacunas contra la COVID-19 y la transparencia de la reglamentación
Zoom/YouTube – 10 - 18 h (HCE)
Programme
10:00 – 10:15
SESSION 1: Opening
- Ms Anabel González, Deputy Director-General, World Trade Organization
Opening remarks - Dr Mariângela Batista Galvão Simão, Assistant Director-General, World Health Organization
Opening remarks - Mr Ricardo Treviño Chapa, Deputy Secretary-General, World Customs Organization
Opening remarks
10:15 – 11:30
SESSION 2: Mapping vaccine manufacturing and trade
Summary Report
- What are the latest projections on COVID-19 vaccine manufacturing output?
- What can supply chain mapping exercises tell us about vaccine manufacturing production and related value chains?
- Vaccine producers are experiencing bottlenecks in their supply chains. Which types of problems are being experienced and what can policy makers do to address them?
MODERATOR: Robert Koopman, Chief Economist, World Trade Organization
- Mr Rasmus Bach Hansen, CEO & Founder, Airfinity
Presentation - Dr Matthew Downham, Sustainable Manufacturing Lead, Coalition for Epidemic Preparedness Innovations
- Ms Giulia del Brenna, Head of Unit for Strategy and Regulation: Single Market and Industrial Policy, Directorate General for Internal Market, Industry, Entrepreneurship and SMEs, (DG Grow) and European Commission Task Force for the Industrial Scale-up of COVID-19 vaccine production
- Mr Andrew Wilson, Global Policy Director, International Chamber of Commerce
- Mr Hongyi Wang, Vice-President, International Business, CanSino Biologics Inc
- Ms Laetitia Bigger, Vaccines Policy Director, International Federation of Pharmaceutical Manufacturers and Associations
Talking points
Five steps to urgently advance COVID-19 vaccine equity - Ms Elsie M. Soto, Vice-President, Supply Chain, Emerging Markets, Pfizer
- Mr Rajiv Gandhi, CEO & Managing Director, Hester Biosciences
- Mr Carel du Marchie Sarvaas, Executive Director, Health for Animals
11:30 – 13:00
SESSION 3: Mapping cross-border movement of vaccine inputs
Summary Report
- What are the vaccines inputs that matter and how are they traded across borders?
- Are trade measures creating bottlenecks in input supply chains, and if so, where and why?
- What approaches can Members and other stakeholders take to facilitate the efficient cross-border movement of vaccine inputs?
- What could be done to improve the monitoring and facilitate these cross-border movements?
MODERATOR: Suja Rishikesh Mavroidis, Director, Market Access Division, °ÄÃÅÁùºÏ²Ê¹ÙÍø×ÊÁÏ
- Mr Dayong Yu, Chief, Market Access Intelligence Section, Economic Research and Statistics Division, World Trade Organization and Mr Roy Santana, Counsellor, Market Access Division
Presentation - Ms Gael Grooby, Deputy Director, Tariff and Trade Affairs Directorate, World Customs Organization
- Ms Silvia Sorescu, Trade Policy Analyst, OECD
- Mr Chad P. Bown, Reginald Jones Senior Fellow, Peterson Institute for International Economics
Vaccine Nationalism Will Prolong the Pandemic
The Tragedy of Vaccine Nationalism
The Real Vaccine Procurement Problem
Presentation - Mr Ronald Antonio Q. Butiong, Chief, Regional Cooperation and Integration Thematic Group, Sustainable Development and Climate Change Department, Asian Development Bank
- Ms Phyllis Arthur, Vice-president, Infectious diseases and diagnostics policy, Biotechnology Innovation Organization
- Mr Thomas Ellman, Vice-President, Life Sciences and Healthcare, Customer Solutions and Innovation, DHL
Delivering Pandemic Resilience revisited
DHL White Paper - Mr Christian Piaget, Head Cargo Border Management, APCS-CARGO, International Air Transport Association
Guidance for Vaccine and Pharmaceutical Logistics and Distribution
- Mr Jens Hügel, Senior Adviser, International Road Transport Union
15:00 – 16:30
SESSION 4: Promoting transparency and convergence in the regulatory landscape
Summary Report
- What approaches are being used to expedite the regulatory processes needed to get new manufacturing capacity up and running?
- How can we cooperate internationally to quickly and safely manufacture, approve and disseminate needed vaccines, therapeutics and diagnostics?
- How can transparency in the regulatory approval process be strengthened?
- How do we increase regulatory cooperation and capacity building for better future pandemic preparedness?
MODERATOR: Aik Hoe Lim, Director, Trade and Environment Division, °ÄÃÅÁùºÏ²Ê¹ÙÍø×ÊÁÏ
- Dr June Raine, Chief Executive, Medicines and Healthcare products Regulatory Agency, UK
- Dr Rogério Gaspar, Director, Regulation and Prequalification Department, WHO
List of WHO guidance on COVID-19 vaccines
Good regulatory practices in the regulation of medical products
Good reliance practices in the regulation of medical products: high level principles and considerations
WHO Good Regulatory and Reliance Practices Launch Webinar - 29 June 2021 - Dr Yasuhiro Fujiwara, Chief Executive, Pharmaceuticals and Medical Devices Agency, Japan
Presentation - Mrs Delese Darko, Chief Executive Officer, Food and Drugs Authority, Ghana
- Mr Rajinder Kumar Suri, Chief Executive Officer, Developing Countries Vaccine Manufacturers' Network
Presentation - Dr Skhumbuzo Ngozwana, CEO of Kiara Health, Chairman of the Board, Biovac
- Mr Alastair West, Business Plan Coordinator, Pharmaceutical Manufacturing Plan for Africa, UNIDO
- Ms Raj Long, Independent Expert Advisor on Regulation and Access
16:30 – 17:45
SESSION 5: Beyond vaccines: mapping other COVID-19 essential health technologies and trade
Summary Report
- How can value chain mapping techniques be used to chart trade in other COVID-19 essential health technologies?
- What manufacturing, input and regulatory bottlenecks are these COVID-19 essential health technologies facing and why?
MODERATOR: Antony Taubman, Director, Intellectual Property, Government Procurement and Competition Division, °ÄÃÅÁùºÏ²Ê¹ÙÍø×ÊÁÏ
- Mr Aaron Bernstein, Divisional Vice President, Procurement Technical Services, Abbott
- Mr Carlos Eduardo Gouvêa, President,
Presentation - Ms Tanya Vogt, Executive Officer, South African Medical Device Industry Association
SAMED COVID-19 Vaccine roll-out policy paper - Dr Trevor Gunn, Vice President for International Relations, Medtronic
Presentation - Ms Hemal Shah, Director, IP & Trade Policy, Government Affairs & Policy, Gilead
17:45 – 18:00
SESSION 6: Closing
- Ms Angela Ellard, Deputy Director-General, World Trade Organization
Closing remarks
Compartir
Si tiene problemas para visualizar esta página,
sírvase ponerse en contacto con [email protected], y proporcionar detalles sobre el sistema operativo y el navegador que está utilizando.